LinkedIn · Nov 2025
The company said the award will help accelerate its first bi-directional chip for reading and writing brain activity.
High-precision, closed-loop neuromodulation devices
Public company, workplace, funding, and market signals
Torpedo Therapeutics is an early-stage neurotechnology/medical-device company building high-precision, closed-loop deep brain stimulation (DBS) systems for neurological disorders. Public sources describe an implantable micro-/nano-fabricated electrode platform, continuous neural sensing, automated stimulation adjustment, and machine-learning-based data analysis. The company was founded in 2018, is based in Cambridge with a Boston office, and appears to operate as a very small private team.
Primary product
High-precision, closed-loop deep brain stimulation (DBS) devices and associated neural-data/control platform
Founded
2018
Headquarters
85 Bolton St, Cambridge, MA 02140, United States
Team size
1-10 employees
Industry
Medical technology
Sub-industry
Closed-loop neuromodulation / deep brain stimulation devices
Offices
0 jobs at Torpedo Therapeutics
Check back later for new openings
Business model
Stage
Seed
Total raised
$5.6M
Latest round
Debt Financing · Dec 2024
Latest amount
$5M
Investors
Differentiators
Technology
Estimated revenue
~$1M estimated ARR
LinkedIn · Nov 2025
The company said the award will help accelerate its first bi-directional chip for reading and writing brain activity.
NEMC / MassTech · Nov 2025
The NEMC Hub announced PROPEL awards, including $187,116 to Torpedo Therapeutics for developing miniaturized implantable brain-computer interfaces with single-neuron precision.
LinkedIn · Mar 2025
Founder and CEO Ingrid van Welie announced the company’s first USPTO patent related to micro-electrodes and adaptive closed-loop DBS stimulation control.
LinkedIn · Oct 2024
Ingrid van Welie announced the company joined NYU Stern’s Endless Frontier Labs cohort, a mentorship program for science/tech startups.
LinkedIn · Mar 2024
Rebrand announcement from Neural Dynamics Technologies Inc. to Torpedo Therapeutics Inc.; the post says the new name reflects the company’s high-precision, closed-loop implantable neuromodulation focus.